Skip to end of metadata
Go to start of metadata

SESSION 1:   BIOLOGY OF RELAPSE AFTER STEM CELL TRANSPLANTATION


Ronald Gress, National Cancer Institute 

SESSION 2:   AUTOLOGOUS STEM CELL TRANSPLANTATION: RELAPSE PREVENTION USING NOVEL AGENTS AND IMMUNOMODULATORY STRATEGIES


SESSION 3:   RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: PREVENTION AND TREATMENT

Christoph Schmid, University of Munich, EBMT
Adjunctive Strategies to Improve Cell Therapy for Relapse

Last updated by Boersma, Brenda (NIH/NCI) [E] on Dec 05, 2012